A recently published phase 2 clinical trial investigated the effects of hyperglycemia in an orthotopic glioblastoma (GBM) xenograft model by combining antihyperglycemic interventions, such as a ketogenic diet and metformin, with the PI3K inhibitor buparlisib. The gene discussed is PIK3CA; the disease is Hyperglycemia.